IDEXX Laboratories (IDXX) Short Interest Ratio & Short Volume $420.91 -2.74 (-0.65%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IDEXX Laboratories Short Interest DataIDEXX Laboratories (IDXX) has a short interest of 2.08 million shares, representing 2.57% of the float (the number of shares available for trading by the public). This marks a -9.17% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.0, indicating that it would take 4.0 days of the average trading volume of 801,090 shares to cover all short positions.Current Short Interest2,080,000 sharesPrevious Short Interest2,290,000 sharesChange Vs. Previous Month-9.17%Dollar Volume Sold Short$846.39 millionShort Interest Ratio4.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares81,890,000 sharesFloat Size81,010,000 sharesShort Percent of Float2.57%Today's Trading Volume690,183 sharesAverage Trading Volume801,090 sharesToday's Volume Vs. Average86% Short Selling IDEXX Laboratories? Sign up to receive the latest short interest report for IDEXX Laboratories and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIDXX Short Interest Over TimeIDXX Days to Cover Over TimeIDXX Percentage of Float Shorted Over Time Ad Darwin2024's Must-Watch Stocks!Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] IDEXX Laboratories Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20242,080,000 shares $846.39 million -9.2%2.6%4 $406.92 10/15/20242,290,000 shares $1.09 billion -3.0%2.8%4.8 $473.92 9/30/20242,360,000 shares $1.19 billion -0.8%2.9%5.1 $505.22 9/15/20242,380,000 shares $1.19 billion +2.2%2.9%5 $500.55 8/31/20242,330,000 shares $1.12 billion -3.3%2.9%4.6 $481.33 8/15/20242,410,000 shares $1.17 billion -1.2%3.0%4.5 $485.52 Get the Latest News and Ratings for IDXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IDEXX Laboratories and its competitors with MarketBeat's FREE daily newsletter. 7/31/20242,440,000 shares $1.16 billion -8.6%3.0%4.4 $476.12 7/15/20242,670,000 shares $1.29 billion -0.7%3.3%5 $482.70 6/30/20242,690,000 shares $1.31 billion +31.2%3.3%5.2 $487.20 6/15/20242,050,000 shares $1.03 billion +17.1%2.5%4.1 $504.00 5/31/20241,750,000 shares $869.66 million +3.6%2.1%3.7 $496.95 5/15/20241,690,000 shares $927.02 million No Change2.1%3.8 $548.53 4/30/20241,690,000 shares $832.76 million -1.2%2.1%3.9 $492.76 4/15/20241,710,000 shares $840.11 million -2.8%2.1%4.1 $491.29 3/31/20241,760,000 shares $950.28 million -2.2%2.1%4.2 $539.93 3/15/20241,800,000 shares $953.59 million +6.5%2.2%4.3 $529.77 2/29/20241,690,000 shares $972.14 million -8.2%2.1%3.7 $575.23 2/15/20241,840,000 shares $1.05 billion -0.5%2.2%3.9 $568.83 1/31/20241,850,000 shares $952.90 million +6.3%2.3%3.8 $515.08 1/15/20241,740,000 shares $931.40 million -5.4%2.1%3.4 $535.29 12/31/20231,840,000 shares $1.02 billion -15.6%2.2%3.5 $555.05 12/15/20232,180,000 shares $1.18 billion -18.1%2.7%4.2 $541.07 11/30/20232,660,000 shares $1.24 billion -4.0%3.2%5.2 $465.82 11/15/20232,770,000 shares $1.28 billion +0.7%3.4%5.7 $460.56 10/31/20232,750,000 shares $1.10 billion No Change3.4%5.8 $399.47 10/15/20232,750,000 shares $1.17 billion +3.8%3.4%6.3 $426.18 9/30/20232,650,000 shares $1.16 billion +7.7%3.2%5.9 $437.27 9/15/20232,460,000 shares $1.11 billion -0.8%3.0%5.4 $450.69 8/31/20232,480,000 shares $1.27 billion +8.3%3.0%5.5 $511.41 8/15/20232,290,000 shares $1.17 billion -12.9%2.8%5 $509.37 7/31/20232,630,000 shares $1.46 billion +6.5%3.2%5.8 $554.73 7/15/20232,470,000 shares $1.33 billion +8.3%3.0%5.6 $536.89 6/30/20232,280,000 shares $1.15 billion +6.1%2.8%5.6 $502.23 6/15/20232,150,000 shares $1.04 billion +3.4%2.6%5.4 $481.42 5/31/20232,080,000 shares $966.72 million -5.9%2.5%5.2 $464.77 5/15/20232,210,000 shares $1.08 billion No Change2.7%5.8 $489.88 10/31/20222,390,000 shares $859.64 million +0.8%2.9%4.5 $359.68 10/15/20222,370,000 shares $769.40 million +14.5%2.9%4.5 $324.64 9/30/20222,070,000 shares $674.41 million -2.8%2.5%3.8 $325.80 9/15/20222,130,000 shares $745.16 million +10.4%2.6%3.8 $349.84Trump’s Back, but DC’s Coming for Your Money! (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov 8/31/20221,930,000 shares $670.91 million -1.5%2.3%3.4 $347.62 8/15/20221,960,000 shares $766.07 million +18.1%2.4%3.3 $390.85 7/31/20221,660,000 shares $662.64 million -12.2%2.0%2.5 $399.18 7/15/20221,890,000 shares $699.56 million -4.6%2.3%2.6 $370.14 6/30/20221,980,000 shares $694.45 million +1.5%2.4%2.8 $350.73 6/15/20221,950,000 shares $651.18 million +7.7%2.3%2.8 $333.94 5/31/20221,810,000 shares $708.83 million +28.4%2.2%2.8 $391.62 5/15/20221,410,000 shares $510.67 million +13.7%1.7%2.2 $362.18 4/30/20221,240,000 shares $533.80 million +17.0%1.5%2.2 $430.48 4/15/20221,060,000 shares $526.59 million +3.9%1.3%2 $496.78 3/31/20221,020,000 shares $558.00 million +20.7%N/A1.9 $547.06 3/15/2022845,000 shares $424.98 million +7.4%1.0%1.7 $502.93 2/28/2022786,800 shares $418.85 million +1.8%0.9%1.6 $532.35 2/15/2022773,000 shares $394.90 million -8.1%0.9%1.6 $510.87 1/31/2022841,000 shares $426.64 million +16.1%1.0%1.9 $507.30 1/15/2022724,700 shares $383.62 million -16.0%N/A0 $529.35 12/31/2021862,400 shares $567.86 million -2.7%1.0%2.4 $658.46 12/15/2021886,000 shares $541.84 million +40.8%1.1%2.5 $611.56 11/30/2021629,400 shares $382.72 million -10.0%0.8%1.6 $608.07 11/15/2021699,600 shares $433.02 million -3.2%0.8%1.8 $618.96 10/29/2021722,700 shares $481.42 million -1.7%0.9%1.9 $666.14 10/15/2021735,400 shares $467.09 million -7.4%0.9%1.9 $635.15 9/30/2021793,900 shares $493.73 million -37.0%0.9%2 $621.90 9/15/20211,260,000 shares $833.68 million +20.0%1.5%3.2 $661.65 8/31/20211,050,000 shares $707.45 million +23.2%1.3%2.9 $673.76 8/13/2021852,500 shares $572.97 million +1.1%1.0%2.4 $672.10 7/30/2021843,000 shares $572.00 million -4.0%1.0%2.4 $678.53 7/15/2021878,200 shares $577.35 million +5.1%1.0%2.5 $657.42 6/30/2021835,300 shares $527.53 million -2.0%1.0%2.4 $631.55 6/15/2021852,200 shares $504.72 million -0.9%1.0%2.4 $592.26 5/28/2021860,000 shares $479.97 million +22.6%1.0%2.3 $558.11 5/14/2021701,300 shares $363.32 million -5.3%0.8%1.7 $518.07 4/30/2021740,200 shares $409.06 million +0.2%0.9%1.6 $552.63 4/15/2021738,700 shares $379.81 million -10.4%N/A0 $514.16 3/31/2021824,500 shares $392.42 million -3.5%1.0%1.8 $475.95 3/15/2021854,300 shares $425.23 million +4.1%1.0%1.9 $497.75 2/26/2021820,700 shares $425.35 million +4.1%1.0%1.8 $518.28 2/12/2021788,700 shares $416.80 million -1.7%0.9%1.9 $528.47 1/29/2021802,500 shares $387.02 million +14.7%1.0%1.9 $482.27 1/15/2021699,800 shares $342.13 million -9.5%0.8%1.7 $488.90 12/31/2020773,200 shares $384.25 million +13.0%0.9%1.9 $496.96 12/15/2020684,500 shares $313.62 million -16.8%0.8%1.7 $458.17 11/30/2020823,100 shares $373.88 million -20.1%1.0%2 $454.23 11/15/20201,030,000 shares $467.25 million +12.1%1.2%2.4 $453.64 10/30/2020919,200 shares $406.10 million -19.4%1.1%2.2 $441.80 10/15/20201,140,000 shares $479.38 million -8.8%1.4%2.7 $420.51 9/30/20201,250,000 shares $491.39 million +2.5%1.5%2.9 $393.11 9/15/20201,220,000 shares $450.47 million No Change1.5%2.7 $369.24 8/31/20201,220,000 shares $477.09 million +0.8%1.5%2.7 $391.06 8/14/20201,210,000 shares $459.07 million -11.7%1.4%2.4 $379.40Trump’s Back, but DC’s Coming for Your Money! (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov 7/31/20201,370,000 shares $544.92 million -13.8%1.6%2.7 $397.75 7/15/20201,590,000 shares $538.17 million -17.6%1.9%3.1 $338.47 6/30/20201,930,000 shares $637.21 million +2.7%2.3%3.6 $330.16 6/15/20201,880,000 shares $581.33 million -8.3%2.2%3.1 $309.22 5/29/20202,050,000 shares $627.57 million -3.8%2.5%2.8 $306.13 5/15/20202,130,000 shares $627.03 million +3.4%2.5%2.9 $294.38 4/30/20202,060,000 shares $570.97 million -0.5%2.5%2.8 $277.17 4/15/20202,070,000 shares $533.69 million +37.1%2.5%2.9 $257.82 3/31/20201,510,000 shares $410.42 million -12.2%1.8%2.1 $271.80 3/13/20201,720,100 shares $444.78 million +35.4%2.0%2.6 $258.58 2/28/20201,270,000 shares $232.33 million -4.5%1.5%2.5 $182.94 2/14/20201,330,000 shares $339.63 million +0.8%1.6%2.7 $255.36 1/31/20201,320,000 shares $342.47 million +9.1%1.6%2.7 $259.45 1/15/20201,210,000 shares $342.89 million -6.9%1.4%2.4 $283.38 12/31/20191,300,000 shares $365.00 million -0.8%1.5%2.7 $280.77 IDXX Short Interest - Frequently Asked Questions What is IDEXX Laboratories' current short interest? Short interest is the volume of IDEXX Laboratories shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 2,080,000 shares of IDXX short. 2.57% of IDEXX Laboratories' shares are currently sold short. Learn More on IDEXX Laboratories' current short interest. What is a good short interest ratio for IDEXX Laboratories? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IDXX shares currently have a short interest ratio of 4.0. Learn More on IDEXX Laboratories's short interest ratio. Which institutional investors are shorting IDEXX Laboratories? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of IDEXX Laboratories: Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Point72 DIFC Ltd, Point72 Asset Management L.P., Parallax Volatility Advisers L.P., Maven Securities LTD, Paloma Partners Management Co, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, Prime Capital Investment Advisors LLC, SpiderRock Advisors LLC, Concourse Financial Group Securities Inc., Cubist Systematic Strategies LLC, Maven Securities LTD, and Point72 Asset Management L.P.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for IDEXX Laboratories? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.57% of IDEXX Laboratories' floating shares are currently sold short. Is IDEXX Laboratories' short interest increasing or decreasing? IDEXX Laboratories saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 2,080,000 shares, a decrease of 9.2% from the previous total of 2,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is IDEXX Laboratories' float size? IDEXX Laboratories currently has issued a total of 81,885,000 shares. Some of IDEXX Laboratories' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IDEXX Laboratories currently has a public float of 81,010,000 shares. How does IDEXX Laboratories' short interest compare to its competitors? 2.57% of IDEXX Laboratories' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to IDEXX Laboratories: Boston Scientific Co. (0.88%), Medtronic plc (0.80%), Becton, Dickinson and Company (0.71%), Edwards Lifesciences Co. (1.33%), ResMed Inc. (5.37%), DexCom, Inc. (2.40%), STERIS plc (1.05%), Insulet Co. (4.05%), Hologic, Inc. (2.12%), Baxter International Inc. (2.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short IDEXX Laboratories stock? Short selling IDXX is an investing strategy that aims to generate trading profit from IDEXX Laboratories as its price is falling. IDXX shares are trading down $2.74 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against IDEXX Laboratories? A short squeeze for IDEXX Laboratories occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IDXX, which in turn drives the price of the stock up even further. How often is IDEXX Laboratories' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IDXX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Boston Scientific Short Interest Medtronic Short Interest Becton, Dickinson and Company Short Interest Edwards Lifesciences Short Interest ResMed Short Interest DexCom Short Interest STERIS Short Interest Insulet Short Interest Hologic Short Interest Baxter International Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IDXX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEXX Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEXX Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
